AVODART Trademark

Trademark Overview

On Friday, October 19, 2001, a trademark application was filed for AVODART with the United States Patent and Trademark Office. The USPTO has given the AVODART trademark a serial number of 78089208. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, March 1, 2024. This trademark is owned by Glaxo Group Limited. The AVODART trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals to treat and prevent urological and prostate related diseases and disorders
avodart

General Information

Serial Number78089208
Word MarkAVODART
Filing DateFriday, October 19, 2001
Status800 - REGISTERED AND RENEWED
Status DateFriday, March 1, 2024
Registration Number2854915
Registration DateTuesday, June 15, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 26, 2002

Trademark Statements

Goods and Servicespharmaceuticals to treat and prevent urological and prostate related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 24, 2001
Primary Code005
First Use Anywhere DateSunday, October 27, 2002
First Use In Commerce DateSunday, October 27, 2002

Trademark Owner History

Party NameGLAXOSMITHKLINE LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808
Party NameSMITHKLINE BEECHAM CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPHILADELPHIA, PA 19102
Party NameSMITHKLINE BEECHAM CORPORATION
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressPHILADELPHIA, PA 19102
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex
GB

Trademark Events

Event DateEvent Description
Friday, March 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, March 1, 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, March 1, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, March 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 11, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, June 15, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 14, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 14, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 28, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, December 28, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, December 28, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 18, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Saturday, December 28, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 18, 2013TEAS SECTION 8 & 9 RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 21, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 21, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 5, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 5, 2012TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 31, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 31, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 19, 2010TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 16, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 9, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 21, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 21, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 15, 2004REGISTERED-PRINCIPAL REGISTER
Wednesday, March 31, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 29, 2004ASSIGNED TO EXAMINER
Friday, March 26, 2004CASE FILE IN TICRS
Thursday, January 15, 2004STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 15, 2004USE AMENDMENT FILED
Thursday, January 15, 2004TEAS STATEMENT OF USE RECEIVED
Wednesday, January 14, 2004SOU EXTENSION 2 GRANTED
Thursday, December 18, 2003SOU EXTENSION 2 FILED
Thursday, December 18, 2003SOU TEAS EXTENSION RECEIVED
Tuesday, August 5, 2003SOU EXTENSION 1 GRANTED
Tuesday, July 22, 2003SOU EXTENSION 1 FILED
Tuesday, July 22, 2003SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2002PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2002NOTICE OF PUBLICATION
Thursday, September 12, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 30, 2002LETTER OF SUSPENSION MAILED
Tuesday, July 16, 2002ASSIGNED TO EXAMINER
Thursday, June 27, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 27, 2002PAPER RECEIVED
Monday, February 18, 2002NON-FINAL ACTION E-MAILED
Saturday, January 12, 2002ASSIGNED TO EXAMINER

Related Keywords

avodart related diseases disorders prostate urological treat prevent pharmaceuticals